Suppr超能文献

血管迷走性晕厥的非侵入性管理

Non-invasive management of vasovagal syncope.

作者信息

Coffin Samuel T, Raj Satish R

机构信息

Autonomic Dysfunction Center, Vanderbilt University School of Medicine, USA; Department of Medicine, Vanderbilt University School of Medicine, USA.

Autonomic Dysfunction Center, Vanderbilt University School of Medicine, USA; Department of Medicine, Vanderbilt University School of Medicine, USA; Department of Pharmacology, Vanderbilt University School of Medicine, USA.

出版信息

Auton Neurosci. 2014 Sep;184:27-32. doi: 10.1016/j.autneu.2014.06.004. Epub 2014 Jun 21.

Abstract

Vasovagal syncope (VVS) is a common disorder of the autonomic nervous system. While recurrent syncope can cause very impaired quality of life, the spells are not generally life-threatening. Both non-pharmacological and pharmacological approaches can be used to treat patients. Conservative management with education, exercise and physical maneuvers, and aggressive volume repletion is adequate for controlling symptoms in most patients. Unfortunately, a minority of patients will continue to have recurrent syncope despite conservative therapy, and they may require medications. These could include vasopressor agents, beta-blockers, or neurohormonal agents. Some patients may require more aggressive device based therapy with pacemakers or radiofrequency ablation, which are emerging therapies for VVS. This paper will review non-procedure based treatments for VVS.

摘要

血管迷走性晕厥(VVS)是自主神经系统的一种常见疾病。虽然反复发作的晕厥会严重损害生活质量,但这些发作通常不会危及生命。非药物和药物治疗方法均可用于治疗患者。通过教育、锻炼和物理手法进行保守治疗,以及积极补充血容量,足以控制大多数患者的症状。不幸的是,少数患者尽管接受了保守治疗仍会反复发作晕厥,他们可能需要药物治疗。这些药物可能包括血管升压药、β受体阻滞剂或神经激素药物。一些患者可能需要更积极的基于器械的治疗,如起搏器或射频消融,这些都是针对VVS的新兴治疗方法。本文将综述VVS的非手术治疗方法。

相似文献

1
Non-invasive management of vasovagal syncope.
Auton Neurosci. 2014 Sep;184:27-32. doi: 10.1016/j.autneu.2014.06.004. Epub 2014 Jun 21.
2
Management of vasovagal syncope.
Auton Neurosci. 2021 Dec;236:102904. doi: 10.1016/j.autneu.2021.102904. Epub 2021 Nov 4.
3
Ongoing clinical trials for Vasovagal Syncope: where are we in 2014?
Auton Neurosci. 2014 Sep;184:77-82. doi: 10.1016/j.autneu.2014.05.009. Epub 2014 May 27.
5
[Overview on the management of vasovagal syncope].
Tunis Med. 2007 Oct;85(10):814-20.
6
Management strategies for vasovagal syncope.
Pacing Clin Electrophysiol. 2021 Dec;44(12):2100-2108. doi: 10.1111/pace.14402. Epub 2021 Nov 23.
7
Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hypotension.
Prog Cardiovasc Dis. 2013 Jan-Feb;55(4):425-33. doi: 10.1016/j.pcad.2012.11.004.
8
The management of vasovagal syncope.
QJM. 2016 Dec;109(12):767-773. doi: 10.1093/qjmed/hcw089. Epub 2016 Jun 23.
9
Current approach to the treatment of vasovagal syncope in adults.
Intern Emerg Med. 2023 Jan;18(1):23-30. doi: 10.1007/s11739-022-03102-w. Epub 2022 Sep 18.
10
Efficacy of tilt training in patients with vasovagal syncope.
Kardiol Pol. 2006 Jun;64(6):602-8; discussion 609-10.

引用本文的文献

1
Advances in diagnosis, management, and long-term outcomes of pediatric vasovagal syncope: a comprehensive review.
Front Cardiovasc Med. 2025 Apr 25;12:1481749. doi: 10.3389/fcvm.2025.1481749. eCollection 2025.
2
Decision-Making in Patients with Vasovagal Syncope: A Preliminary Study.
Biology (Basel). 2023 Jun 29;12(7):930. doi: 10.3390/biology12070930.
3
Post-COVID Dysautonomias: The Importance of Early Recognition and Implementation of Recovery Programs.
Arq Bras Cardiol. 2023 Mar;120(3):e20230110. doi: 10.36660/abc.20230110.
4
Clinical Efficacy of Empirical Therapy in Children with Vasovagal Syncope.
Children (Basel). 2022 Jul 17;9(7):1065. doi: 10.3390/children9071065.
6
Autonomic Dysfunction in Cardiology: Pathophysiology, Investigation, and Management.
Can J Cardiol. 2017 Dec;33(12):1524-1534. doi: 10.1016/j.cjca.2017.09.008. Epub 2017 Sep 14.

本文引用的文献

1
Implantable rhythm devices in the management of vasovagal syncope.
Auton Neurosci. 2014 Sep;184:33-9. doi: 10.1016/j.autneu.2014.05.012. Epub 2014 May 27.
2
Prognosis after tilt training in patients with recurrent vasovagal syncope.
Int J Cardiol. 2013 Oct 9;168(4):4264-5. doi: 10.1016/j.ijcard.2013.04.125. Epub 2013 Apr 30.
3
Norepinephrine transport inhibition for treatment of vasovagal syncope.
J Cardiovasc Electrophysiol. 2013 Jul;24(7):799-803. doi: 10.1111/jce.12111. Epub 2013 Feb 27.
4
Age-dependent effect of β-blockers in preventing vasovagal syncope.
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):920-6. doi: 10.1161/CIRCEP.112.974386. Epub 2012 Sep 12.
5
Rationale for the prevention of syncope trial IV: assessment of midodrine.
Clin Auton Res. 2012 Dec;22(6):275-80. doi: 10.1007/s10286-012-0167-5. Epub 2012 May 19.
6
Cardiac output and sympathetic vasoconstrictor responses during upright tilt to presyncope in healthy humans.
J Physiol. 2012 Apr 15;590(8):1839-48. doi: 10.1113/jphysiol.2011.224998. Epub 2012 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验